Phil S. Baran Professor at Scripps Research Ross T. Burn Chief Executive Officer at CatSci Ltd Kelly Chibale Neville Isdell Chair in African-Centric Drug Discovery & Development and South Africa Research Chair in Drug Discovery John Chiminski Chair and Chief Executive Officer at Catalent Pharma Solutions Paolo Colombo Emeritus Professor at the University of Parma Athena Countouriotis President and Chief Executive Officer at Turning Point Therapeutics Will Downie Chief Executive Officer at Vectura Edward Haeggström Chief Executive Officer at Nanoform Alison Holmes Professor of Infectious Diseases at Imperial College London Johannes Khinast Professor of Pharmaceutical Engineering at Graz University of Technology and CEO of RCPE Nik Kotecha Chairman of Morningside Pharmaceuticals Ltd M. N. V. Ravi Kumar Professor at the University of Alabama in Tuscaloosa Robert S. Langer David H. Koch Institute Professor at the Massachusetts Institute of Technology Nigel Langley Global Technology Director at BASF Andrew Moore General Manager at Pfizer CentreOne Faith Osier Group Leader, Malaria Vaccine Development at KEMRI – Wellcome, Kenya and Visiting Professor of Immunology at Oxford University GV Prasad Co-Chairman and Managing Director at Dr. Reddy’s Laboratories John Talley Chief Scientific Officer at Euclises Pharmaceuticals Matthew Todd Professor of Drug Discovery at University College London Martin VanTrieste President and Chief Executive Officer at Civica Rx
